These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 15671652)
1. High throughput assay technologies for ion channel drug discovery. Zheng W; Spencer RH; Kiss L Assay Drug Dev Technol; 2004 Oct; 2(5):543-52. PubMed ID: 15671652 [TBL] [Abstract][Full Text] [Related]
2. Flux assays in high throughput screening of ion channels in drug discovery. Gill S; Gill R; Lee SS; Hesketh JC; Fedida D; Rezazadeh S; Stankovich L; Liang D Assay Drug Dev Technol; 2003 Oct; 1(5):709-17. PubMed ID: 15090243 [TBL] [Abstract][Full Text] [Related]
3. Impact of novel screening technologies on ion channel drug discovery. Lü Q; An WF Comb Chem High Throughput Screen; 2008 Mar; 11(3):185-94. PubMed ID: 18336212 [TBL] [Abstract][Full Text] [Related]
4. High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology. Dunlop J; Bowlby M; Peri R; Vasilyev D; Arias R Nat Rev Drug Discov; 2008 Apr; 7(4):358-68. PubMed ID: 18356919 [TBL] [Abstract][Full Text] [Related]
5. High throughput screening technologies for ion channels. Yu HB; Li M; Wang WP; Wang XL Acta Pharmacol Sin; 2016 Jan; 37(1):34-43. PubMed ID: 26657056 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic scope of modulation of non-voltage-gated cation channels. Li S; Gosling M; Poll CT; Westwick J; Cox B Drug Discov Today; 2004 Dec; 9(24):1045-54. PubMed ID: 15582793 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic scope of modulation of non-voltage-gated cation channels. Li S; Gosling M; Poll CT; Westwick J; Cox B Drug Discov Today; 2005 Jan; 10(2):129-37. PubMed ID: 15718162 [TBL] [Abstract][Full Text] [Related]
8. Nonradioactive rubidium ion efflux assay and its applications in drug discovery and development. Terstappen GC Assay Drug Dev Technol; 2004 Oct; 2(5):553-9. PubMed ID: 15671653 [TBL] [Abstract][Full Text] [Related]
9. Exploiting high-throughput ion channel screening technologies in integrated drug discovery. Treherne JM Curr Pharm Des; 2006; 12(4):397-406. PubMed ID: 16472135 [TBL] [Abstract][Full Text] [Related]
10. High-throughput screening for ion channel modulators. Falconer M; Smith F; Surah-Narwal S; Congrave G; Liu Z; Hayter P; Ciaramella G; Keighley W; Haddock P; Waldron G; Sewing A J Biomol Screen; 2002 Oct; 7(5):460-5. PubMed ID: 14599362 [TBL] [Abstract][Full Text] [Related]
11. Assay technologies for screening ion channel targets. Mattheakis LC; Savchenko A Curr Opin Drug Discov Devel; 2001 Jan; 4(1):124-34. PubMed ID: 11727318 [TBL] [Abstract][Full Text] [Related]
12. The second annual ion channel retreat. Despotovski S; Razvi E Assay Drug Dev Technol; 2004 Oct; 2(5):575-8. PubMed ID: 15671656 [TBL] [Abstract][Full Text] [Related]
13. Ion channel profiling to advance drug discovery and development. Zou B Drug Discov Today Technol; 2015 Nov; 18():18-23. PubMed ID: 26723888 [TBL] [Abstract][Full Text] [Related]
14. Contribution of Automated Technologies to Ion Channel Drug Discovery. Picones A; Loza-Huerta A; Segura-Chama P; Lara-Figueroa CO Adv Protein Chem Struct Biol; 2016; 104():357-378. PubMed ID: 27038379 [TBL] [Abstract][Full Text] [Related]
15. HTS techniques for patch clamp-based ion channel screening - advances and economy. Farre C; Fertig N Expert Opin Drug Discov; 2012 Jun; 7(6):515-24. PubMed ID: 22507077 [TBL] [Abstract][Full Text] [Related]
16. [Fluorescent and electrophysiological high-throughput screening technologies for exploratory research on voltage-dependent ion channels]. Sawada K; Hihara H; Yoshinaga T Nihon Yakurigaku Zasshi; 2005 Nov; 126(5):321-7. PubMed ID: 16394576 [No Abstract] [Full Text] [Related]
17. Recent advances in electrophysiology-based screening technology and the impact upon ion channel discovery research. Southan A; Clark G Methods Mol Biol; 2009; 565():187-208. PubMed ID: 19551363 [TBL] [Abstract][Full Text] [Related]
18. Automated patch clamping using the QPatch. Jones KA; Garbati N; Zhang H; Large CH Methods Mol Biol; 2009; 565():209-23. PubMed ID: 19551364 [TBL] [Abstract][Full Text] [Related]
19. Design of an automated enhanced-throughput platform for functional characterization of positive allosteric modulator-induced leftward shifts in apparent agonist potency in vitro. Hendricson A; Matchett M; Ferrante M; Ferrante C; Hunnicutt E; Westphal R; Kostich W; Huang Y; Masias N; Hong D; Bertekap R; Burford N; Watson J; Alt A; Myslik J; Zhang L; Knox R J Lab Autom; 2012 Apr; 17(2):104-15. PubMed ID: 22357567 [TBL] [Abstract][Full Text] [Related]
20. QPatch: the missing link between HTS and ion channel drug discovery. Mathes C; Friis S; Finley M; Liu Y Comb Chem High Throughput Screen; 2009 Jan; 12(1):78-95. PubMed ID: 19149494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]